AgenT-797 Combination with Checkpoint Inhibitors and Bispecific Engagers Expands Anti-Cancer Benefit PRAME-TCR iNKT Overcomes Challenges from Conventional TCR-T Cells in Solid Cancers NEW YORK ...

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...

The dashboard states West Bengal generates 7,875.55 tonnes per day (TPD) of solid waste daily but processes only 588.65 TPD.

Idaho State (4-5) seized control of what had been a tight contest at the half, with a dominant third quarter. Then they rode out an aggressive Pioneers defense to earn a 73-61 win Wednesday night.

The Bengal government has decided to start 78 solid waste management projects across the state to maintain cleanliness in forests and tourist hotspots. A government official said that despite repeated ...

Bengal fought hard and clawed their way back into the match on the second day of their Cooch Behar encounter against Maharashtra. Matches (14) ... Das ton puts Bengal in solid position.

POCATELLO, Idaho (KIFI) - Future Bengals were checking out their future home in Pocatello on Saturday. Idaho State University held its Bengal Visit Day on campus. This day provided high school ...

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. cell therapies to treat cancer and other immune-mediated diseases, today announced plans to present updated clinical data and ...

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...

MiNK Therapeutics has a proprietary library of phospho-peptide neoantigens derived from a wide range of solid tumors and hematologic malignancies. In this collaborative effort, ImmunoScape will ...

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...

AgenT-797 Combination with Checkpoint Inhibitors and Bispecific Engagers Expands Anti-Cancer Benefit PRAME-TCR iNKT Overcomes Challenges from Conventional TCR-T Cells in Solid Cancers NEW YORK ...